AVITA Medical, Inc.
AVITA Medical, Inc.（RCEL）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · RCEL · 截至 2026年6月9日
活动摘要
买入笔数
10
P-Purchase only
卖出笔数
0
近12个月
买卖比
∞
Buy/Sell (by trades)
整体情绪
AVITA Medical, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
RCEL 季度内部人买卖趋势
RCEL 内幕交易卖出 · RCEL 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · RCEL CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
RCEL 高管卖出股份 · RCEL 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 3, 2026 | Woody Joseph Fralin Director | Purchase | 5,000 | $20K | Form 4 |
| Jun 3, 2026 | Woody Joseph Fralin Director | Purchase | 5,000 | $20K | Form 4 |
| Jan 20, 2026 | McNamara Robert Director | Award | 22,214 | — | Form 4 |
| Jan 20, 2026 | Woody Joseph Fralin Director | Award | 22,214 | — | Form 4 |
| Jan 5, 2026 | Woody Joseph Fralin Director | Award | 40,547 | — | Form 4 |
| Jan 20, 2026 | Tarnoff Michael E Director | Award | 22,214 | — | Form 4 |
| Aug 6, 2025 | Tarnoff Michael E Director | Award | 26,250 | — | Form 4 |
| Jan 20, 2026 | COOK JEREMY CURNOCK Director | Award | 22,214 | — | Form 4 |
| Jan 20, 2026 | Crowe Suzanne Director | Award | 22,214 | — | Form 4 |
| Jan 20, 2026 | REED JAN STERN Director | Award | 22,214 | — | Form 4 |
| May 29, 2026 | O'Toole David D CFO | Award | 5,000 | $15K | Form 4 |
| May 29, 2026 | Vance Cary Guy President and CEO · Director | Award | 5,000 | $15K | Form 4 |
| May 20, 2026 | O'Toole David D CFO | Purchase | 2,000 | $9K | Form 4 |
| May 19, 2026 | O'Toole David D CFO | Purchase | 2,000 | $8K | Form 4 |
| Mar 11, 2026 | O'Toole David D CFO | Purchase | 1,800 | $9K | Form 4 |
| Feb 19, 2026 | O'Toole David D CFO | Purchase | 3,000 | $12K | Form 4 |
| Feb 18, 2026 | O'Toole David D CFO | Award | 105,470 | — | Form 4 |
| Feb 18, 2026 | KELSEY NICOLE Chief Legal Officer | Award | 98,390 | — | Form 4 |
| Aug 28, 2025 | McNamara Robert Director | Purchase | 10,000 | $45K | Form 4 |
| Aug 26, 2025 | O'Toole David D CFO | Purchase | 2,000 | $9K | Form 4 |
| Aug 19, 2025 | McNamara Robert Director | Purchase | 10,000 | $50K | Form 4 |
| Aug 12, 2025 | O'Toole David D CFO | Purchase | 2,000 | $10K | Form 4 |
| Jan 21, 2025 | Vance Cary Guy Director | Award | 10,022 | — | Form 4 |
| Jan 21, 2025 | REED JAN STERN Director | Award | 10,022 | — | Form 4 |
| Jan 21, 2025 | McNamara Robert Director | Award | 10,022 | — | Form 4 |
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 RCEL 内幕交易
RCEL 内幕交易
AVITA Medical, Inc.（RCEL）内幕交易数据来源于公司内部人（包括O'Toole David D (CFO), Woody Joseph Fralin (Director), McNamara Robert (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。RCEL内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看AVITA Medical, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
RCEL 内幕交易 · 5个问题AVITA Medical, Inc.（RCEL）的内部人包括高管和董事，如O'Toole David D (CFO), Woody Joseph Fralin (Director), McNamara Robert (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026